1. Home
  2. CADL vs CPZ Comparison

CADL vs CPZ Comparison

Compare CADL & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$4.67

Market Cap

280.3M

Sector

Health Care

ML Signal

HOLD

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

HOLD

Current Price

$14.29

Market Cap

297.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
CPZ
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
280.3M
297.4M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
CADL
CPZ
Price
$4.67
$14.29
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$18.50
N/A
AVG Volume (30 Days)
1.3M
72.8K
Earning Date
06-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$14.38
52 Week High
$9.08
$16.82

Technical Indicators

Market Signals
Indicator
CADL
CPZ
Relative Strength Index (RSI) 36.72 31.56
Support Level $4.57 N/A
Resistance Level $6.16 $15.13
Average True Range (ATR) 0.23 0.21
MACD -0.01 -0.05
Stochastic Oscillator 5.06 9.87

Price Performance

Historical Comparison
CADL
CPZ

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

Share on Social Networks: